The frequency of small intestine bacterial overgrowth syndrome in cystic fibrosis patients - A pilot study;Czȩstość wystȩpowania zespołu jelitowego przerostu bakteryjnego w mukowiscydozie - Doniesienie wstȩpne

Pediatria Wspolczesna

Volumn 11, Issue 1, 2009, Pages 19-22

  Lisowska, Aleksandra ^a   Popiel, Anna ^b   Cichy, Woiciech ^a   Korytowska Niklas, Agnieszka ^b   Walkowiak, Jarostaw ^a,c  

^a Klinika Gastroenterologii Dzieciecej i Chorob Metabolicznych   (Poland)

^b Klinika Pneumonologii Alergologii Dzieciecej I Immunologii Klinicznej III   (Poland)

^c Zakad Dietetyki Katedry Higieny Zywienia Czowieka Uniwersytetu Przyrodniczego W Poznaniu   (Poland)

Author keywords

Cystic fibrosis; Hydrogen methane breath test; Small intestine bacterial overgrowth syndrome

Indexed keywords

GLUCOSE; HYDROGEN;

ADOLESCENT; AIRWAY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL OVERGROWTH; BODY MASS; BODY WEIGHT; BREATH ANALYSIS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INGESTION; LUNG FUNCTION; MALE; MORBIDITY; NUTRITIONAL STATUS; PANCREAS SECRETION; PILOT STUDY; PRESCHOOL CHILD; PSEUDOMONAS AERUGINOSA; RISK FACTOR; SCHOOL CHILD; SMALL INTESTINE;

EID: 67651036888     PISSN: 15075532     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Walkowiak J.: Fecal elastase-1 test - clinical value in the assessment of exocrine pancreatic function in children. Eur. J. Pediatr., 2001, 31, 11-15.
2. Walkowiak J.: Ocena zewna̧trzwydzielniczej funkcji trzustki u chorych na mukowiscydozȩ. Przeg. Pediatr., 2001, 31, 11-15.
3. Zasady rozpoznawania i leczenia mukowiscydozy - stanowisko Polskiej Grupy Roboczej Mukowiscydozy. Karpacz-Warszawa, maj-październik 2002.
4. Eggermont E.: Gastrointestinal manifestation in cystic fibrosis. Eur. J. Gastroenterol. Hepatol., 1996, 8, 731-738.
5. Walkowiak J., Oralewska B., Celińska-Cedro D. i wsp.: Gastroesophageal reflux in children with cystic fibrosis is more frequent in postprandial time. Pediatr. Współ. Gastroenterol. Hepatol. Żywienie Dzieci, 2004, 6, 113-116.
6. Walkowiak J., Kostrzewa-Szymiec D., Cichy W.: Choroby przewodu pokarmowego w mukowiscydozie. Pediatr. Prakt., 1994, 2, 213-220.
7. Cichy W., Socha J.: Współczesne pogla̧dy no kolonopatiȩ włóknieja̧ca̧ u pacjentów z mukowiscydoza̧. Gastroenterol. Pol., 1997, 4, 309-314.
8. Gregory P.C.: Gastrointestinal pH, motility/transit and permeability in cystic fibrosis. J. Pediatr. Gastroenterol. Nutr., 1996, 23, 513-523.
9. Sokol R.J., Durie P.R.: Recommendations for management of liver and biliary tract disease in cystic fibrosis. J. Pediatr. Gastroenterol. Nutr., 1999, 28, 1-13.
10. Armbrecht U., Bosaeus I., Gillberg R. i wsp.: Hydrogen (H2) breath test and gastric bacteria in acid-secreting subjects and in achlorhydric and postgastrectomy patients before and after antimicrobial treatment. Scand. J. Gastroenterol., 1985, 20, 805-813.
11. Bouhnik Y., Alain S., Attar A. i wsp.: Bacterial populations contaminating the upper gut in patients with small intestinal bacterial overgrowth syndrome. Am. J. Gastroenterol., 1999, 94, 1327-1331.
12. Husebye E.: The pathogenesis of gastrointestinal bacterial overgrowth. Chemotherapy, 2005, 51, 1-22.
13. Elphick D.A., Chew T.S., Higham S.E. i wsp.: Small bowel bacterial overgrowth in symptomatic older people: can it be diagnosed earlier? Gerontology, 2005, 51, 396-401.
14. Singh V.V., Toskes P.P.: Small bowel bacterial overgrowth: presentation, diagnosis and treatment. Curr. Gastroenterol. Rep., 2003, 5, 365-372.
15. Di Stefano M., Miceli E., Missanelli A. i wsp.: Absorbable vs. non-absorbable antibiotics in the treatment of small intestine bacterial overgrowth in patients with blind-loop syndrome. Aliment. Pharmacol. Ther., 2005, 21, 985-992.
16. Lewindon P.J., Robb T.A., Moore D.J. i wsp.: Bowel disfunction in cystic fibrosis: importance of breath testing. J. Paediatr. Child Health, 1998, 34, 79-82.
17. Borowitz D., Durie P.R., Clarke L.L. i wsp.: Gastrointestinal outcomes and confounders in cystic fibrosis. J. Pediatr. Gastroenterol. Nutr., 2005, 41,273-285.
18. De Lisle R.C., Roach E.A., Norkina O.: Eradication of small intestinal baterial overgrowth in the cystic fibrosis mouse reduces mucus accumulation. J. Pediatr. Gastroentrol. Nutr., 2006, 42, 46-52.
19. Meyers J.S., Ehrenpreis E.D., Craig R.M.: Small intestinal bacterial overgrowth syndrome. Curr. Treat. Options Gastroenterol., 2001, 4, 7-14.
20. Majewski M., Reddymasu S.C., Sostarich S. i wsp.: Efficacy of rifaximin, a nonabsorbed oral antibiotic, in the treatment of small intestinal bacterial overgrowth. Am. J. Sci., 2007, 5, 266-270.
21. Scarpellini E., Gabrielli M., Lauritano C.E. i wsp.: High dosage rifaximin for the treatment of small intestinal bacterial overgrowth. Aliment. Pharmacol. Ther., 2007, 7, 781-786.
22. Fridge J., Castillo R., Conrad C. i wsp.: Small bowel bacterial overgrowth in cystic fibrosis. Gastroenterology, 2005, 128, S1205.
23. Dalzell A.M., Freestone N.S., Billington D. i wsp.: Small intestinal permeability and orocaecal transit time in cystic fibrosis. Arch. Dis. Child., 1990, 65, 585-588.
24. Gregory P.C.: Gastrointestinal pH, motility/transit and permeability in cystic fibrosis. J. Pediatr. Gastroenterol. Nutr., 1996, 23, 513-523.
25. Nousia-Arvanitakis S.: Cystic fibrosis and the pancreas. J. Clin. Gastroenterol., 1999, 29, 138-142.
26. Fridge J.L., Conrad C., Gerson L. i wsp.: Risk factors for small bowel bacterial overgrowth in cystic fibrosis. J. Pediatr. Gastroenterol. Nutr., 2007, 44, 212-218.
27. Goldin E., Wengrower D.: Diarrhea in hypothyroidism: bacterial overgrowth as a possible etiology. J. Clin. Gastroenterol., 1990, 12, 98-99.
28. O'Brien S., Mulcahy H., Fenlon H. i wsp.: Intestinal bile acid malabsorption in cystic fibrosis. Gut, 1993, 3, 1137-1141.